Stryker Corporation (SYK): Morphing Into A Value Rebound Play

Stryker Corporation (NYSE:SYK) stock enjoyed an overall uptrend of 4.24% from the beginning of 2019. The closing share price quoted for January 16, 2019 was $163.4. The 0.78% rally might have...

Etsy, Inc. (ETSY): The Growth Story Continues – Price Target Set At $56.83

Some analysts have a lowest price target on Etsy, Inc. (NASDAQ:ETSY) of $48, which would mean a -11.98% gain in value. The closing share price quoted for January 16, 2019 was...

Analysts Shift Tapestry, Inc. (TPR) High Price Target To $63

Tapestry, Inc. (NYSE:TPR) closing share price quoted for January 16, 2019 was $35.3. The -1.67% drop might have been tempting for an investor to sell at this point but in fact...

Annaly Capital Management, Inc. (NLY) Target Raised To 8.06% Upside

The 0.89% rally in Annaly Capital Management, Inc. (NYSE:NLY) might have been tempting for an investor to buy at this point and in fact that would prove a good idea, as...

Washington Prime Group Inc. (WPG) This Volatile Stock Needed A Break

Washington Prime Group Inc. (NYSE:WPG) stock enjoyed an overall uptrend of 8.64% from the beginning of 2019. The closing share price quoted for January 16, 2019 was $5.28. The 0.57% rally...

Can Merck & Co., Inc. (MRK) Gain Another 27.33%

The average 12-month price target analysts expect from Merck & Co., Inc. (NYSE:MRK) is $82.49. This mean price target represents 10.56% upside over its previous closing price. The stock enjoyed an...

Analysts Clamor Over Valuing Zoetis Inc. (ZTS)

Some analysts have a lowest price target on Zoetis Inc. (NYSE:ZTS) of $67, which would mean a -19.48% gain in value. The closing share price quoted for January 16, 2019 was...

At What Point Should You Sell? UDR, Inc. (UDR)

UDR, Inc. (NYSE:UDR) closing share price quoted for January 16, 2019 was $41.28. The 1.1% rally might have been tempting for an investor to buy at this point and in fact...

NovoCure Limited (NVCR): A Rude Awakening

The 1.71% rally in NovoCure Limited (NASDAQ:NVCR) might have been tempting for an investor to buy at this point and in fact that would prove a good idea, as sell-side analysts...

Correvio Pharma Corp. (CORV): An Undervalued Beast

Correvio Pharma Corp. (NASDAQ:CORV) stock enjoyed an overall downtrend of -8.43% from the beginning of 2019. The closing share price quoted for January 16, 2019 was $2.28. The 4.59% rally might...

HOT NEWS